Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome
T Mehra, K Ikenberg, RM Moos, R Benz… - JAMA …, 2015 - jamanetwork.com
Importance The prognosis of advanced cutaneous T-cell lymphoma (CTCL), including
Sézary syndrome and mycosis fungoides (MF), is poor. So far, no curative option apart from …
Sézary syndrome and mycosis fungoides (MF), is poor. So far, no curative option apart from …
[HTML][HTML] Role of liver magnetic resonance imaging in hyperferritinaemia and the diagnosis of iron overload
A Rüfer, C Bapst, R Benz, J Bremerich, N Cantoni… - Swiss medical …, 2017 - smw.ch
Hyperferritinaemia is a frequent clinical problem. Elevated serum ferritin levels can be
detected in different genetic and acquired diseases and can occur with or without anaemia …
detected in different genetic and acquired diseases and can occur with or without anaemia …
Human L-ferritin deficiency is characterized by idiopathic generalized seizures and atypical restless leg syndrome
A Cozzi, P Santambrogio, D Privitera… - Journal of Experimental …, 2013 - rupress.org
The ubiquitously expressed iron storage protein ferritin plays a central role in maintaining
cellular iron homeostasis. Cytosolic ferritins are composed of heavy (H) and light (L) …
cellular iron homeostasis. Cytosolic ferritins are composed of heavy (H) and light (L) …
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
R Benz, K Arn, M Andres, T Pabst, M Baumann… - Blood …, 2020 - ashpublications.org
Hairy cell leukemia (HCL) remains an incurable disease. However, first-line treatment with
either intravenous or subcutaneous cladribine generally leads to long-lasting remissions …
either intravenous or subcutaneous cladribine generally leads to long-lasting remissions …
[HTML][HTML] The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients …
The β-3 sympathomimetic agonist BRL37344 restored nestin-positive cells within the stem
cell niche, and thereby normalized blood counts and improved myelofibrosis in a mouse …
cell niche, and thereby normalized blood counts and improved myelofibrosis in a mouse …
[HTML][HTML] Autoimmune hematologic disorders in two patients after mRNA COVID-19 vaccine
ME Gaignard, S Lieberherr, A Schoenenberger… - …, 2021 - journals.lww.com
Since the occurrence of SARS-CoV-2 infections in late 2019,> 3.4 million people died of
COVID-19 worldwide and many more suffered from its severe complications and long-term …
COVID-19 worldwide and many more suffered from its severe complications and long-term …
Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012
N Bonadies, A Feller, A Rovo, A Ruefer, S Blum… - Cancer …, 2017 - Elsevier
Myelodysplastic syndromes (MDS) are emerging disorders of the elderly with an increasing
burden on healthcare systems. He we report on the first population-based, epidemiological …
burden on healthcare systems. He we report on the first population-based, epidemiological …
[HTML][HTML] Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported …
A Rovó, N Cantoni, K Samii, A Rüfer, G Koenen, S Ivic… - Plos one, 2022 - journals.plos.org
Aims of the study Thrombopoietin receptor agonists (TPO-RAs) are approved for immune
thrombocytopenia (ITP), but their impact on health-related quality of life (HRQoL) remains …
thrombocytopenia (ITP), but their impact on health-related quality of life (HRQoL) remains …
[HTML][HTML] Myelodysplastic syndromes in the postgenomic era and future perspectives for precision medicine
I Chanias, K Stojkov, GT Stehle, M Daskalakis… - Cancers, 2021 - mdpi.com
Simple Summary With demographic ageing, improved cancer survivorship and increased
diagnostic sensitivity, incident cases of patients with Myelodysplastic Syndromes (MDS) are …
diagnostic sensitivity, incident cases of patients with Myelodysplastic Syndromes (MDS) are …
Long‐term follow‐up of interferon‐alpha induction and low‐dose maintenance therapy in hairy cell leukemia
R Benz, RD Siciliano, G Stussi… - European journal of …, 2009 - Wiley Online Library
Objective: Interferon‐α (IFNα) was the first effective pharmacologic treatment of hairy cell
leukemia (HCL). Since 1990 purine analogs replaced IFNα because of higher rates of …
leukemia (HCL). Since 1990 purine analogs replaced IFNα because of higher rates of …